mutations demonstrate different effects on transcript levels Deficiency in the A-subunit of coagulation factor XIII: two novel point

[1]  E. Ikkala,et al.  Transfusion Therapy in Factor XIII (F. S. F.) Deficiency , 2009 .

[2]  H. Nevanlinna The Finnish population structure. A genetic and genealogical study. , 2009, Hereditas.

[3]  D. Bowen,et al.  Factor XIII ABristol 1: detection of a nonsense mutation (Arg171→+stop codon) in factor XIII A subunit deficiency , 1993, British journal of haematology.

[4]  A. Ichinose,et al.  Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII. , 1993, Blood.

[5]  D. Cooper,et al.  Human gene mutations affecting RNA processing and translation. , 1993, Annals of medicine.

[6]  P. Board,et al.  Identification of a point mutation in factor XIII A subunit deficiency. , 1992, Blood.

[7]  T. Kamura,et al.  Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5' end of exon III. , 1992, The Journal of clinical investigation.

[8]  L. Peltonen,et al.  Quantitative determination of rare mRNA species by PCR and solid-phase minisequencing. , 1992, PCR methods and applications.

[9]  A. Palotie,et al.  N‐ras gene mutations in acute myeloid leukemia: Accurate detection by solid‐phase minisequencing , 1992, International journal of cancer.

[10]  L. Peltonen,et al.  Acceleration of chronic myeloid leukemia correlates with calcitonin gene hypermethylation. , 1991, Blood.

[11]  W. Stüber,et al.  A Photometric Assay for Blood Coagulation Factor XIII , 1991, Thrombosis and Haemostasis.

[12]  L. Peltonen,et al.  Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. , 1991, The EMBO journal.

[13]  K Kontula,et al.  A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. , 1990, Genomics.

[14]  E. Davie,et al.  Nucleotide sequence of the gene for the b subunit of human factor XIII. , 1990, Biochemistry.

[15]  E. Davie,et al.  Structure of transglutaminases. , 1990, The Journal of biological chemistry.

[16]  A. Syvänen,et al.  Direct sequencing of affinity‐captured amplified human DNA application to the detection of apolipoprotein E polymorphism , 1989, FEBS letters.

[17]  M. Poon,et al.  Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies. , 1989, The Journal of clinical investigation.

[18]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Erickson,et al.  Electron microscopy and hydrodynamic properties of factor XIII subunits. , 1989, The Journal of biological chemistry.

[20]  J. Enghild,et al.  Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of cross-linking fibrin(ogen). , 1988, The Biochemical journal.

[21]  E. Davie,et al.  Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[23]  Y. Kan,et al.  Localization of the gene for coagulation factor XIII a-chain to chromosome 6 and identification of sites of synthesis. , 1987, The Journal of clinical investigation.

[24]  K. Fujikawa,et al.  Amino acid sequence of the a subunit of human factor XIII. , 1986, Biochemistry.

[25]  Y. Takahashi,et al.  Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Blau,et al.  Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed , 1983, Molecular and cellular biology.

[27]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[28]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Mcdonagh,et al.  Factor XIII deficiency: a genetic study of two affected kindreds in Finland. , 1974, Blood.

[30]  J. Perheentupa,et al.  Hereditary diseases in Finland; rare flora in rare soul. , 1973, Annals of clinical research.

[31]  S. Pizzo,et al.  Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. , 1973, The Journal of biological chemistry.

[32]  F. Duckert DOCUMENTATION OF THE PLASMA FACTOR XIII DEFICIENCY IN MAN , 1972, Annals of the New York Academy of Sciences.

[33]  C. Laurell,et al.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. , 1966, Analytical biochemistry.

[34]  R. Ádány,et al.  Immunohistochemical detection of factor XIII subunit a in histiocytes of human uterus , 2004, Histochemistry.

[35]  A. Palotie,et al.  Development of molecular genetic methods for monitoring myeloid malignancies. , 1993, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[36]  G. Webb,et al.  Localization of the coagulation factor XIII A subunit gene (F13A) to chromosome bands 6p24----p25. , 1988, Cytogenetics and cell genetics.

[37]  F. Duckert,et al.  A Hitherto Undescribed Congenital Haemorrhagic Diathesis Probably Due to Fibrin Stabilizing Factor Deficiency , 1961, Thrombosis and Haemostasis.